Search research articles
Contact Us
Filters
Showing results (221-230 of 231) with videos related to
Page
of 24
Sort By:
Blood Neoplasia
|
April 24, 2026
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma
Lorea Jordana-Urriza, Guillermo Serrano, Sergio Camara-Peña, et al.
Blood
|
June 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial
Juan-Jose Lahuerta, Jesús F San-Miguel, Ana Jiménez-Ubieto, et al.
The New England Journal of Medicine
|
December 12, 2023
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Pieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
The New England Journal of Medicine
|
December 9, 2025
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
Luciano J Costa, Nizar J Bahlis, Aurore Perrot, et al.
Future Oncology (London, England)
|
September 17, 2024
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
Pieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Nature Medicine
|
March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
International Journal of Public Health
|
May 7, 2025
Corrigendum: Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study
María Camila Sossa-Alarcón, Mónica Paola Gutiérrez, Natalia Becerra, et al.
International Journal of Public Health
|
April 2, 2025
Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study
María Camila Sossa-Alarcón, Mónica Paola Gutiérrez, Natalia Becerra, et al.
Blood
|
January 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma
Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 231) with videos related to
Sort By:
Page
of 24
Blood Neoplasia
|
April 24, 2026
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma
Lorea Jordana-Urriza, Guillermo Serrano, Sergio Camara-Peña, et al.
Blood
|
June 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial
Juan-Jose Lahuerta, Jesús F San-Miguel, Ana Jiménez-Ubieto, et al.
The New England Journal of Medicine
|
December 12, 2023
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Pieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
The New England Journal of Medicine
|
December 9, 2025
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
Luciano J Costa, Nizar J Bahlis, Aurore Perrot, et al.
Future Oncology (London, England)
|
September 17, 2024
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
Pieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Nature Medicine
|
March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
International Journal of Public Health
|
May 7, 2025
Corrigendum: Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study
María Camila Sossa-Alarcón, Mónica Paola Gutiérrez, Natalia Becerra, et al.
International Journal of Public Health
|
April 2, 2025
Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study
María Camila Sossa-Alarcón, Mónica Paola Gutiérrez, Natalia Becerra, et al.
Blood
|
January 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma
Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
Page
of 24